Preview

Pediatric pharmacology

Advanced search

Overview of International Neonatal Screening Programs

https://doi.org/10.15690/pf.v22i4.2942

Abstract

Neonatal screening (NS) is significant method for early detection of hereditary diseases that reduces the risk of severe complications and improves patients’ quality of life. Enhanced neonatal screening covering 36 diseases has been implemented in Russian Federation since 2023. It includes hereditary metabolic diseases, spinal muscular atrophy, and primary immunodeficiencies. This study presents comparative analysis of NS programs in Russian Federation and in countries of the Eurasian Economic Union and 11 member countries of the Organization for Economic Cooperation and Development. Key trends in the diagnosis of included hereditary diseases in world practice, as well as directions for further programs improvement are identified.

About the Authors

Sergey V. Voronin
Research Centre for Medical Genetics
Russian Federation

MD, PhD 

Moscow 


Disclosure of interest:

Not specified. 



Vitaly V. Omelyanovskiy
Center for Healthcare Quality Assessment and Control ; Russian Medical Academy of Continuous Professional Education
Russian Federation

MD, PhD, Professor 

Moscow 


Disclosure of interest:

Not specified. 



Polina A. Mukhortova
Center for Healthcare Quality Assessment and Control
Russian Federation

Polina A. Mukhortova 

6/20, Pokrovsky Boulevard, building 2, Moscow, 109028, +7 (495) 783-19-05, доб. 153 


Disclosure of interest:

Not specified. 



A. A. Slabikova
Center for Healthcare Quality Assessment and Control ; Russian Medical Academy of Continuous Professional Education
Russian Federation

Moscow 


Disclosure of interest:

Not specified. 



References

1. Donnikov MYu. Effektivnost’ rannei diagnostiki mukovistsidoza u detei na regional’nom urovne (na primere KHMAO — Yugry). [abstract of dissertation]. Perm’; 2020. 22 p. (In Russ).

2. Maliyevsky ОA, Murzabayeva SSh., Klimentyeva MM. Neonatal screening for hypothyroidism: economic aspects. Problems of Endocrinology. 2006;52(5):1–5. (In Russ). doi: https://doi.org/10.14341/probl20065251-5

3. Matulevich SA. Massovyi skrining novorozhdennykh na nasledstvennye bolezni obmena kak chast’ sistemy medikogeneticheskoi pomoshchi naseleniiu. [dissertation]. Moscow; 2009. 211 p. (In Russ).

4. Pechatnikova NL, Zakharova EYu, Izhevskaya VL. Evaluation of the clinical and economic effectiveness of newborn screening programs for inborn errors of metabolism. Medical Genetics. 2020;19(10):4–9. (In Russ). doi: https://doi.org/10.25557/2073-7998.2020.10.4-9

5. Aleksandr Beglov: V Peterburge vpervye v Rossii zapustiat neontal’nyi skrining novorozhdennykh po redkoi nasledstvennoi bolezni obmena veshchestv. In: Administration of St. Petersburg: Official website. (In Russ). Доступно по: https://www.gov.spb.ru/press/governor/297739. Ссылка активна на 25 мая 2025.

6. Free newborn screening program. In: The State Support Programs Information Platform: Official website (In Arm). Available online: https://irazekum.am/event/view/213. Accessed on May 3, 2025.

7. Krasovskii I. Malen’kie radosti: v Minske zapustili novyi skrining novorozhdennykh. In: Tochka: Website. (In Russ). Доступно по: https://tochka.by/articles/life/malenkie_radosti_v_minske_zapustili_novyy_skrining_novorozhdennykh. Ссылка активна на 3 мая 2025.

8. O vazhnosti neontal’nogo skrininga. In: 1st Cyti Clinical Hospital: Official website. (In Russ). Доступно по: https://1gkb.by/home/information/vrachi-informiruyut/informiruet-vrach-ginekolog/o-vazhnostineonatalnogo-skrininga. Ссылка активна на 3 мая 2025.

9. Neonatal’nyi skrining: zachem on nuzhen i kak provoditsia rasskazali v Almaty. In: Department of Public Health of Almaty: Official website. (In Russ). Доступно по: https://www.gov.kz/memleket/entities/almaty-densaulyk/press/news/details/951304. Ссылка активна на 3 мая 2025.

10. V Kyrgyzstane nachali massovyi skrining detei na nasledstvennye zabolevaniia. In: SPUTNIK Kyrgyzstan: Website. (In Russ). Доступно по: https://ru.sputnik.kg/20231027/kyrgyzstan-deti-zabolevaniyaskrining-1079933975.html. Ссылка активна на 3 мая 2025.

11. Newborn screening. In: Medical University of Vienna: Official website. Available online: https://kinder-jugendheilkunde.meduniwien.ac.at/en/about-us/newborn-screening. Accessed on May 25, 2025.

12. Österreichisches Neugeborenen-Screening. In: Medical University of Vienna: Official website. Available online: https://kinder-jugendheilkunde.meduniwien.ac.at/fileadmin/content/OE/Kinder_und_Jugendheilkunde/neugeborenenscreening/NGS_Folder_2022-v17.pdf. Accessed on May 25, 2025.

13. What is screened in the program. In: Australian Government Department of Health and Aged Care: Official website. Available online: https://www.health.gov.au/our-work/newborn-bloodspotscreening/what-is-screened. Accessed on May 25, 2025.

14. Newborn screening. In: NHS: Official website. Available online: https://www.nhs.uk/baby/newborn-screening. Accessed on May 25, 2025.

15. Neugeborenen-Screening auf angeborene Stoffwechselstörungen. In: AWMF: Official website. Available online: https://register.awmf.org/assets/guidelines/024-012l_S2k_Neugeborenenscreening_2022-02-abgelaufen.pdf. Accessed on May 25, 2025.

16. Neugeborenen-Screening zur Erkennung von Stoffwechselerkrankungen. In: Deutscher Bundestag: Official website. Available online: https://www.bundestag.de/resource/blob/1031516/52fe55e8a6663c9a3a628faa96080661/WD-8-075-24-pdf. Accessed on May 25, 2025.

17. ADA-SCID: in Abruzzo quasi 5.000 neonati già sottoposti a screening. In: Osservatorio Screening: Official website. Available online: https://www.osservatorioscreening.it/ada-scid-deficit-diaadc-e-sindrome-adrenogenitale-in-abruzzo-quasi-5-000-neonatigia-sottoposti-a-screening. Accessed on May 25, 2025.

18. Screening neonatale malattie metaboliche lisosomiali. In: Osservatorio Screening: Official website. Available online: https://www.osservatorioscreening.it/screening-neonatale-malattielisosomiali. Accessed on May 25, 2025.

19. Verso l’introduzione dello screening neonatale. In: Osservatorio Screening: Official website. Available online: https://www.osservatorioscreening.it/verso-lintroduzione-dello-screeningneonatale-per-la-leucodistrofia-metacromatica-in-emilia-romagna. Accessed on May 25, 2025.

20. Pannello patologie screening metabolico allargato. In: Osservatorio Screening: Official website. Available online: https://www.osservatorioscreening.it/pannello-malattie. Accessed on May 25, 2025.

21. Screening neonatale SMA. In: Osservatorio Screening: Official website. Available online: https://www.osservatorioscreening.it/screening-neonatale-sma-gia-attivo-in-sette-regioni-italianee-in-via-di-introduzione-in-altre-quattro. Accessed on May 25, 2025.

22. Newborn blood spot screening in the Netherlands. Monitor 2023. In: RIVM: Official website. Available online: https://www.pns.nl/sites/default/files/2025-02/HielprikMon2023-EN.pdf. Accessed on May 25, 2025.

23. Clinical picture | Pre- and neonatal screenings. In: RIVM: Official website. Available online: https://www.pns.nl/en/heel-prick/clinical-picture. Accessed on May 25, 2025.

24. Expansion of the heel prick. In: RIVM: Official website. Available online: https://www.pns.nl/hielprik/professionals/uitbreiding. Accessed on May 25, 2025.

25. Toward a Future Pan-Canadian Coordinated Approach for Newborn Screening. In: Canadian Medical Association: Official website. Available online: https://www.cda-amc.ca/sites/default/files/DRD/HC0079-NBS_Recommendations_Report.pdf. Accessed on May 25, 2025.

26. Newborn screening for spinal muscular atrophy. In: Haute Autorité de Santé: Official website. Available online: https://www.has-sante.fr/jcms/p_3451353/en/newbornscreening-for-spinal-muscular-atrophy-advance-assessmentof-extension-of-screening-to-the-general-population-in-france. Accessed on May 25, 2025.

27. Health Technology Assessment of the addition of SCID screening. In: Haute Autorité de Santé: Official website. Available online: https://www.hassante.fr/upload/docs/application/pdf/2022-04/summary_preliminary_assessment_of_universal_newborn_screening_for_severe_combined_immunodeficiency_by_trecs_quantification_i.pdf. Accessed on February 3, 2025.

28. Diseases and defects detected in screening tests. In: Polish Institute of Mother and Child: Official website. Available online: https://przesiew.imid.med.pl/choroby.html. Accessed on May 25, 2025.

29. Recommended Uniform Screening Panel. In: HRSA: Official website. Available online: https://newbornscreening.hrsa.gov/about-newborn-screening/recommended-uniform-screening-panel. Accessed on May 25, 2025.

30. Newborn Screening and Its Target Diseases. In: Japanese Society for Neonatal Screening: Official website. Available online: https://www.jsms.gr.jp/contents04-02.html. Accessed on May 25, 2025.

31. Explanation of Newborn Screening. In: Ministry of Health, Labour and Welfare (Japan): Official website. Available online: https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iryou/kokusai/setsumeisiryo/dl/en49.pdf. Accessed on May 25, 2025.

32. Status of Expanded Screening by Prefecture. In: Japanese Society for Neonatal Screening: Official website. Available online: https://www.jsms.gr.jp/download/3.Exp_Screening_list_241003(revised250226).pdf. Accessed on May 25, 2025.


Review

For citations:


Voronin S.V., Omelyanovskiy V.V., Mukhortova P.A., Slabikova A.A. Overview of International Neonatal Screening Programs. Pediatric pharmacology. 2025;22(4):395-405. (In Russ.) https://doi.org/10.15690/pf.v22i4.2942

Views: 15


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)